Synthesis and Antimicrobial Activity of Newly Synthesized Nicotinamides

Antioxidants are promising compounds with antimicrobial activity against drug-resistant pathogens, especially when combined with conventional antimicrobials. Our study aimed to characterize the structure of nicotinamides synthesized from nicotinic acid and thiocarbohydrazones and to evaluate their a...

Full description

Saved in:
Bibliographic Details
Main Authors: Bojana Anić Marković (Author), Aleksandar Marinković (Author), Jelena Antić Stanković (Author), Stefan Mijatović (Author), Ilija Cvijetić (Author), Milena Simić (Author), Irena Arandjelović (Author)
Format: Book
Published: MDPI AG, 2024-08-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_d37449f0ec6d46178ecde351a9ed4ca3
042 |a dc 
100 1 0 |a Bojana Anić Marković  |e author 
700 1 0 |a Aleksandar Marinković  |e author 
700 1 0 |a Jelena Antić Stanković  |e author 
700 1 0 |a Stefan Mijatović  |e author 
700 1 0 |a Ilija Cvijetić  |e author 
700 1 0 |a Milena Simić  |e author 
700 1 0 |a Irena Arandjelović  |e author 
245 0 0 |a Synthesis and Antimicrobial Activity of Newly Synthesized Nicotinamides 
260 |b MDPI AG,   |c 2024-08-01T00:00:00Z. 
500 |a 10.3390/pharmaceutics16081084 
500 |a 1999-4923 
520 |a Antioxidants are promising compounds with antimicrobial activity against drug-resistant pathogens, especially when combined with conventional antimicrobials. Our study aimed to characterize the structure of nicotinamides synthesized from nicotinic acid and thiocarbohydrazones and to evaluate their antibacterial and antifungal activity. Seven nicotinic acid hydrazides (NC <b>1</b>-<b>7</b>) were synthesized using mono-thiocarbohydrazones with hydroxyl group substituents, along with quinolone, phenolic, and pyridine rings known for their antimicrobial activity. The in vitro antimicrobial activity of NC <b>1</b>-<b>7</b>, at concentrations ranging from 0.001 to 1 mM, was tested against <i>Staphylococcus aureus</i> (ATCC 6538), <i>Enterococcus faecalis</i> (ATCC 29212), <i>Pseudomonas aeruginosa</i> (ATCC 27853), <i>Klebsiella pneumoniae</i> (NCIMB 9111), and <i>Candida albicans</i> (ATCC 24433) using the broth microdilution method per EUCAST 2024 guidelines. Microorganism survival percentages were calculated based on optical density, and target fishing using the PharmMapper database identified potential molecular targets. The results showed that <i>P. aeruginosa</i> was most susceptible to the compounds, while <i>C. albicans</i> was the least susceptible. NC <b>3</b> significantly inhibited <i>P. aeruginosa</i> and <i>K. pneumoniae</i> growth at 0.016 mM, while higher concentrations were required for <i>S. aureus</i>, <i>E. faecalis</i>, and <i>C. albicans</i>. NC <b>5</b> was most effective against gram-positive bacteria at 0.03 mM. Only NC <b>4</b> completely inhibited <i>C. albicans</i> below 1 mM. NC <b>3</b>, with the lowest concentration for 50% growth inhibition (0.016-0.064 mM), showed promising antibacterial potential against specific AMR-related proteins (bleomycin resistance protein, HTH-type transcriptional regulator QacR, and streptogramin A acetyltransferase), suggesting that this class of compounds could enhance or restore the activity of established antibiotics. 
546 |a EN 
690 |a nicotinamides 
690 |a nicotinic acid 
690 |a thiocarbohydrazones 
690 |a antimicrobial activity 
690 |a Pharmacy and materia medica 
690 |a RS1-441 
655 7 |a article  |2 local 
786 0 |n Pharmaceutics, Vol 16, Iss 8, p 1084 (2024) 
787 0 |n https://www.mdpi.com/1999-4923/16/8/1084 
787 0 |n https://doaj.org/toc/1999-4923 
856 4 1 |u https://doaj.org/article/d37449f0ec6d46178ecde351a9ed4ca3  |z Connect to this object online.